Correlation Between Simris Alg and XSpray Pharma
Specify exactly 2 symbols:
By analyzing existing cross correlation between Simris Alg AB and XSpray Pharma AB, you can compare the effects of market volatilities on Simris Alg and XSpray Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Simris Alg with a short position of XSpray Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Simris Alg and XSpray Pharma.
Diversification Opportunities for Simris Alg and XSpray Pharma
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Simris and XSpray is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Simris Alg AB and XSpray Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XSpray Pharma AB and Simris Alg is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Simris Alg AB are associated (or correlated) with XSpray Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XSpray Pharma AB has no effect on the direction of Simris Alg i.e., Simris Alg and XSpray Pharma go up and down completely randomly.
Pair Corralation between Simris Alg and XSpray Pharma
Assuming the 90 days trading horizon Simris Alg AB is expected to under-perform the XSpray Pharma. In addition to that, Simris Alg is 2.26 times more volatile than XSpray Pharma AB. It trades about -0.07 of its total potential returns per unit of risk. XSpray Pharma AB is currently generating about -0.01 per unit of volatility. If you would invest 4,870 in XSpray Pharma AB on September 12, 2024 and sell it today you would lose (340.00) from holding XSpray Pharma AB or give up 6.98% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Simris Alg AB vs. XSpray Pharma AB
Performance |
Timeline |
Simris Alg AB |
XSpray Pharma AB |
Simris Alg and XSpray Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Simris Alg and XSpray Pharma
The main advantage of trading using opposite Simris Alg and XSpray Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Simris Alg position performs unexpectedly, XSpray Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XSpray Pharma will offset losses from the drop in XSpray Pharma's long position.Simris Alg vs. SenzaGen AB | Simris Alg vs. AAK AB | Simris Alg vs. Scibase AB | Simris Alg vs. Scandinavian Enviro Systems |
XSpray Pharma vs. Bavarian Nordic | XSpray Pharma vs. BioPorto | XSpray Pharma vs. Zaptec AS | XSpray Pharma vs. cBrain AS |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |